Diagnostics
Biotherapeutics specialist Geneos Therapeutics has clinched US$17m in second-round funding to help its development of tumour neoantigen targeted personalised immunotherapies for liver cancer patients. Led by Flerie Invest and backed by Santé Ventures, Korea Investment Partners – Global Bio Fund and INOVIO Pharmaceuticals, the investment will be used to bolster Geneos' GT-30 Phase Ib/IIa clinical [...]
Live-cell assay systems specialist Axion BioSystems of Atlanta, Georgia has purchased Netherlands-based CytoSMART Technologies for its kinetic live-cell imaging analysis. Terms were not disclosed. The acquisition aims to boost Axion's expansion into stem cell research, immuno-oncology cell-based therapies and drug discovery. Non-invasively studying the real-time biology of live cells allows scientists to obtain a more [...]
Incidental findings overlooked in medical imaging procedures harm millions of patients and cost untold legal fees and damages, claims a recent study. Northwestern Medicine in the US found that nationally health systems spend an estimated $43 million each year on lawsuits for missed follow-ups on lung findings alone. Delayed and missed referrals on incidental diagnostic [...]
Spanish biotech KeyZell is aiming for €5m in funding to conduct a human clinical trial for its novel brain cancer treatment. Based on company founder Dr.Nabil Hajji's research on cellular apoptosis induced by cell receptor blockage, the start-up will also use the investment to improve its AI system to personalise treatment for each cancer patient. Collaborating [...]
Doctors regard hypertension or high blood pressure as a silent killer. People may have high blood pressure but are entirely unaware of their condition. As most individuals do not experience any symptoms, many resume their daily lives without receiving the treatment to ensure their longevity and overall health. Whether you are suffering from hypertension or [...]
The study will further validate Pilloxa's full suite of medication support services, including their adherence app and a digitally connected pillbox to enable remote patient support
Research from Imperial College London and University College London has found that a new type of ultrasound scan can diagnose most prostate cancer cases In a clinical trial involving 370 men, the ultrasound scans missed just 4.3 per cent of clinically important prostate cases, cancer that should be treated rather than monitored in comparison to [...]
The report shows a steady growth with some key markets maintaining their position as global leader
The funding will allow the company to expand and hire more key staff members
England’s first Rare Diseases Action Plan has been published to mark Rare Disease Day 2022
